Data revealed that MI resulted in overexpression of TGF-β1 and Smad2/3 in myocardium, and the overexpression of TGF-β1 and Smad2/3 was decreased significantly after mice been treated with jatrorrhizine. The gene discussed is SMAD2; the disease is myocardial infarction.